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Carcinoids and Capsules: A Case Series Highlighting the 
Utility of Capsule Endoscopy in Patients With Small Bowel 
Carcinoids
Michael G. Noujaima, e, f, Jonathan Greenb, e, May Minc, Christopher R. Schlieveb,  
Krunal Patelc, d, Mitchell Cahanb, David Cavec, d
Abstract
Background: Neuroendocine tumors (NETs) or carcinoids arise at 
many different sites of the gastrointestinal tract. The small intestine is 
the most common site for NETs. Diagnosing small bowel carcinoids 
remains challenging given their non-specific presentations and the 
overall low incidence of small bowel tumors. Video capsule endosco-
py (VCE) has significanly improved our ability to detect small bowel 
malignancies. We explore the value of VCE in the initial workup and 
management of a series of small bowel carcinoid patients.
Methods: We retrospectively analyzed adult patients undergoing sur-
gical management for small bowel lesions from July 2005 to Septem-
ber 2015 at a tertiary care center. Patient characteristics, presenting 
symptomatology, diagnostic workup and surgical management were 
analyzed among patients with histologically confirmed small bowel 
carcinoid tumors.
Results: Our study identified 16 patients treated surgically for small 
bowel carcinoids. The majority of patients (87.5%) presented with ei-
ther occult gastrointestinal bleeding or anemia. Most patients (87.5%) 
were initially evaluated with various endoscopic and imaging modali-
ties before all ultimately undergoing surgery. Seventy-five percent of 
patients had a VCE, with 83.3% (10/12) having positive findings that 
correlated with intraoperative findings compared to 62.5% (5/8) with 
computed tomography scan, 21.4% (3/14) with colonoscopy, 44% 
(4/9) with deep enteroscopy, and 0% (0/9) with esophagogastroduo-
denoscopy (EGD).
Conclusions: In the absence of any contraindications, VCE is an ef-
fective endoscopic modality in the diagnostic workup of small bowel 
NETs. Furthermore, positive VCE findings appear to highly correlate 
with surgical findings, thus suggesting a valuable role for VCE in the 
initial surgical assessment of patients with small bowel NETs.
Keywords: Carcinoid; Neuroendocrine tumors; Small bowel; Video 
capsule endoscopy; Surgical resection
Introduction
Neuroendocrine tumors (NETs) - formerly known as carci-
noids - arise at many sites throughout the body, including, the 
lungs, gastrointestinal (GI) tract, hepatobiliary system, pan-
creas, and reproductive organs [1]. The GI tract is the most 
common site for NETs, accounting for 60% of tumors, with 
the small bowel comprising 42% of all GI NETs [1, 2]. Di-
agnosing small bowel NETs remains challenging given their 
non-specific presentations and low incidence, accounting for 
approximately 1.4% of all GI malignancies [3]. Despite their 
low incidence, neoplasms of the small intestine are responsi-
ble for 75% of the symptomatic small bowel lesions requiring 
surgical intervention [4, 5], making their timely detection and 
accurate localization highly pertinent.
Computed tomography (CT) and magnetic resonance im-
aging (MRI) are the most commonly used modalities for the 
initial evaluation of suspected small bowel NETs given their 
good sensitivity, specificity, and availability [2, 6]. Neverthe-
less, despite their overall relatively high sensitivities, both CT 
and MRI have been limited in their usefulness for detecting GI 
NETs, particularly in the small intestine [2]. In recent years, 
video capsule endoscopy (VCE) has significanly improved 
the ability to detect small bowel malignancies with multiple 
studies demonstrating a clear superiority for VCE in detect-
ing small bowel tumors compared to radiologic imaging [7]. 
VCE is most commonly indicated in cases of overt or occult 
obscure GI bleeding (OGIB), which is a common presenting 
symptom of small bowel malignancies, including NETs [7]. 
Current literature demonstrates that VCE is more accurate in 
detecting malignant and benign small bowel masses compared 
to CT and barium studies [8]. However, current literature does 
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not specifically demonstrate the utility of VCE in identifying 
small bowel carcinoids.
In this study, we retrospectively explore the value and util-
ity of VCE in the initial workup and management of 16 surgi-
cally confirmed small bowel NET cases.
Patients and Methods
Patient population
A retrospective chart analysis was performed on adult patients 
(≥ 18 years of age) who underwent open or laparoscopic ab-
dominal surgery for suspected small bowel lesions in the 
jejunum or ileum at a tertiary care center from July 2005 to 
September 2015. Only surgically resected cases with histologi-
cally proven NETs were included in the study. Study design 
and conduct was reviewed and approved by the University of 
Massachusetts Medical School’s institutional review board.
Data collection
Medical charts were reviewed for patient demographic char-
acteristics, co-morbidities, pre-operative imaging/workup, en-
doscopic interventions, hospital course and disposition. Study 
data were collected in REDCap (Research Electronic Data 
Capture) electronic data capture tools hosted at the University 
of Massachusetts Medical School. REDCap is a secure, web-
based application designed to support data capture for research 
studies, providing 1) an intuitive interface for validated data 
entry; 2) audit trails for tracking data manipulation and export 
procedures; 3) automated export procedures for seamless data 
downloads to common statistical packages; and 4) procedures 
for importing data from external sources [9].
Results
Patient characteristics
Our study identified 16 patients treated surgically for small 
bowel NETs. The mean age of the study sample was approxi-
mately 64 years old, over half were female (56%), and all were 
Caucasian. The majority of patients (87.5%) presented with 
chronic symptoms and the most common presenting symp-
toms were OGIB and anemia (87.5%). Over one-third (37.5%) 
of patients had abdominal pain associated with obstructive 
symptoms (diarrhea, nausea, and vomiting) on presentation 
(Table 1).
Endoscopy and imaging findings
Almost all of the patients (87.5%) were initially evaluated with 
one or more of the endoscopic and/or imaging modalities listed 
in Table 2. Notably, three-quarters (75%) were evaluated using 
VCE. All 16 patients ultimately underwent surgical therapy. 
When retrospectively compared to the other endoscopic and 
imaging modalities, VCE not only detected small bowl tumors 
more often than the other studies, it also was the only modality 
whose positive findings most highly correlated with intraop-
erative findings in terms of location, tumor morphology, and 
Table 1.  Patient Characteristics
All patients (n = 16)
Age (mean, years) 64 ± 12.5
Male (%) 7 (44)
Race (%)
  Caucasian 16 (100)
Co-morbidities
  Body mass index (kg/m2) 28.2 ± 10.3
  Tobacco use 6 (37.5)
  History of cancer 3 (19)
Presentation
  Acute 1 (6.25)
  Chronic 14 (87.5)
  Acute-on-chronic 1 (6.25)
Symptoms
  GI bleed 9 (56.2)
  Anemia 5 (31.2)
  Nausea/vomit 4 (25)
  Diarrhea 3 (19)
  Abdominal pain 6 (37.5)
Values are N (%) or mean (standard deviation) unless otherwise speci-
fied.
Table 2.  Endoscopy and Imaging Findings
All patients (n = 16)
Overall Positive finding§
Endoscopy
  EGD 9 (56) 0 (0)
  Colonoscopy 14 (87) 3 (21.4)
  Video capsule endoscopy 12 (75) 10 (83.3)
  Deep enteroscopy 9 (56) 4 (44)
  None 2 (12.5) -
Radiology
  X-ray 2 (12.5) 0 (0)
  CT 8 (50) 5 (62.5)
  CTE 4 (25) 3 (75)
  MRE 2 (12.5) 1 (50)
  None 4 (25) -
Values are N (%) unless otherwise specified. §Positive finding that cor-
related to operative findings/location.
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number of lesions (Fig. 1).
Operative details and final histopathology
Over two-thirds (68.7%) of patients underwent a small bowel 
resection with primary anastomosis, four (25%) had an ile-
ocecectomy due to the ileocecal location of their tumor(s) and 
one patient had a small bowel resection and a cecectomy due 
to a multifocal lesion. Only five patients had a pre-operative 
clinical diagnosis of NET; nevertheless, all 16 patients had a 
final postoperative, histologically proven diagnosis of GI NET 
(Table 3).
Upon surgical resection, 75% of patients had multiple le-
sions. Two patients had only a single jejunal mass, 11 patients 
had only ileal involvement and three patients had both jejunal 
and ileal lesions. Final histopathologic examination revealed 
that all specimens invaded at least the submucosa and 75% had 
either vascular, lympatic or neural invasion.
Follow-up and survival
There was only one 30-day readmission for wound abscess 
and Clostridium difficile infection. Median follow-up time 
was 53.5 months (6 - 98) with over two-thirds (68.7%) of 
patients being asymptomatic at the time of follow-up. Four 
patients (25%) had diarrhea and three patients (18.75%) had 
either obstruction, nausea/vomitting or abdominal pain at 
Table 3.  NET Characteristics in the Surgical Pathology Report
All patients (n = 16)
Depth of invasion
  Serosa 6 (37.5)
  Muscularis 7 (43.7)
  Submucosa 3 (18.7)
  Mucosa 0 (0)
Neurovascular invasion
  Vascular 6 (37.5)
  Local lymph node(s) 11 (68.7)
  Neural 1 (6.25)
  No invasion 4 (25)
Final histologic diagnosis
  Carcinoid (NET) 16 (100)
Values are N (%) unless otherwise specified.
Figure 1. Examples of small bowel neuroendocrine tumors (carcinoids) detected on video capsule endoscopy.
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follow-up. All 16 patients were alive at 30-day follow-up. At 
the time of our chart review, only two patients had died due to 
metastatic disease - notably, both patients initially presented 
with obstructive symptoms, received no endoscopic interven-
tions, and were found to have mutliple lesions upon surgical 
resection. Nevertheless, both patients were alive, although 
symptomatic (diarrhea/vomiting) at > 80 months follow-up. 
In general, even though small and metastatic to local nodes, 
none of the NETs in this cohort had recurred after surgical 
resection (Table 4).
Discussion
In this retrospective case series, we demonstrate the useful-
ness of VCE in the initial workup and detection of small bowel 
NETs. Over the past decade, VCE has surfaced as a valuable 
tool in the diagnosis of small bowel lesions, particularly in pa-
tients presenting with OGIB and/or with clinical suspicion for 
small bowel malignancies [8, 10, 11]. By enabling visualiza-
tion of the full length of the small intestines, VCE allows for a 
diagnosis and focused treatment. In a recent prospective study 
comparing wireless capsule endoscopy with intraoperative en-
teroscopy in patients with OGIB, one study found VCE had 
a sensitivity, specificity, and positive and negative predictive 
value of capsule endoscopy were 95%, 75%, 95%, and 86%, 
respectively [12]. Furthermore, a prospective study involving 
28 patients admitted with OGIB compared VCE, CT angiogra-
phy and standard angiography in detecting a bleeding source. 
The study found that VCE detected a source of bleeding in 
72% of patients, compared to 24% by CT angiography and 
56% by standard angiography [13]. In addition, VCE has been 
shown to have higher diagnostic yields compared to current 
imaging and endoscopic modalities [8, 10, 11]. For instance, a 
recent meta-analysis by Triester et al looking at three studies 
with a total of 88 patients revealed a yield of 67% for VCE 
compared to 8% for small bowel radiographic studies [11]. 
The same analysis found VCE to be superior to both push ent-
eroscopy and small bowel barium imaging for the diagnosis of 
clinical pathology in patients with OGIB [11]. Another recent 
retrospective cohort demonstrated that benign and malignant 
small bowel masses were more frequently identified on VCE 
compared to barium studies and CT findings [8].
In our present study, 75% (12/16) of patients had a VCE, 
with 83.3% (10/12) having positive findings that correlated 
with intraoperative findings compared to 62.5% (5/8) with CT 
scan, 21.4% (3/14) with colonoscopy, 44% (4/9) with deep 
enteroscopy, and 0% (0/9) with esophagogastroduodenoscopy 
(EGD). This is consistent with current literature that demon-
strates high diagnositic yield of VCE [8, 10, 11]. As a result, 
our findings are in line with the growing body of literature 
highlighting the advantage and utility of VCE compared to 
other endoscopic and imaging modalites in detecting and 
diagnosing small bowel pathology. Furthermore, the natural 
history of small bowel NETs even with local metastases ap-
pears different from those presenting with pain, diarrhea and 
obstruction. Our findings suggest that small bowel NETs may 
behave differently from NETs arising in other anatomic sites.
Conclusion
In patients for whom there are no contraindications, VCE is 
an effective, non-invasive, and reliable endoscopic modality in 
the diagnostic workup of small bowel tumors, including NETs. 
Furthermore, positive VCE findings appear to highly correlate 
with surgical findings, thus suggesting a valuable role for VCE 
in the initial surgical assessment of patients with small bowel 
NETs.
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